CARLSBAD, Calif. and BOSTON, Mass. – July 26, 2019 – The twelfth annual BioPharm America™ will welcome hundreds of global life science executives seeking strategic opportunities for new deals advancing drug development partnerships. Registration is currently up over 30%, with a huge increase in investors also attending. As part of Biotech Week Boston, the event is produced by EBD Group and will take place September 11–12 at the Boston Convention & Exhibition Center.
Of the 15 events offered at Biotech Week Boston, BioPharm America is the one focused on facilitating valuable one-to-one meetings among pharma, established biotech, startups and investors with the efficient, easy-to-navigate gold standard partnering system, partneringONE®. The platform has been enhanced to an even more robust and powerful experience, with extended search capabilities, access to attendees’ meeting profiles from all past EBD events, and a responsive mobile platform.
Partnering opens July 31. Register now to take full advantage of the early scheduling rounds.
New this year, BioPharm America attendees will also have access to partnering with participants from three other events held concurrently: AI Applications for Drug Discovery and Development, Microbiome Therapeutics US, and Cell & Gene Therapy Bioprocessing & Commercialization.
“Each year, BioPharm America plays a vital role in connecting emerging biotech with companies that seek to work with them, facilitating partnerships that drive growth and innovation,” said Anna Chrisman, Group Managing Director, EBD Group. “The event draws industry leaders from around the globe to this unique partnering event in one of the most innovative biotech hubs in the world.”
Hear top experts in the industry during the Xcelerate keynote series, “The Future of Oncology and Genetic Medicine,” including Laurie Glimcher, President and CEO of the Dana-Farber Cancer Institute; David Liu, Co-Founder, Beam Therapeutics & Editas Medicine and Vice Chair of Faculty, Broad Institute; Cindy Perettie, CEO of Foundation Medicine; Saurabh Saha, Senior VP R&D and Global Head of Translational Medicine at Bristol-Myers Squibb; and Luk Vandenberghe, Director of Grousbeck Gene Therapy Center at Massachusetts Eye and Ear.
Highlights of the panels with key industry leaders, pharma executives, and investors include:
Besides partnering, the event provides robust opportunities to meet industry experts and network with investors including presentation opportunities, a startup pitch competition, and informal networking at parties open to all Biotech Week Boston attendees, a total of over 4,500 life science leaders.
Additional links and information:
Follow BioPharm America on Twitter: @EBDGroup (hashtag: #BioPharmUSA).
About EBD Group
EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio® Partnering Forum, Rare Disease Innovation and Partnering Summit, Cell & Gene Meeting on the Med, and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.
Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life science industry. EBD Group is an Informa company.
+1 760 930 0500